Licorice root extract 수출 진단 (Health Options Europe)

Tridge 데이터와 무관한 제품·시장 본질 적합도

Confirmed: Germany/EU market entry for food or supplement uses is compliance-heavy rather than automatic; BfR states foods imported into Germany must comply with food law, and food supplements require BVL notification with label submission. Confirmed: India subjects imported food consignments to FSSAI document scrutiny, inspection, and possible sampling/testing before clearance. Not fully confirmed in this research run: product-specific import demand figures for licorice extract in the five target countries, the exact customs classification/route for powder versus block, China-specific category treatment, Iceland-specific implementation details, and any product-specific tariff rate for Iran-origin shipments.

수출 난이도 (규제·무역·인증)

This request is intrinsically difficult because the same licorice extract may be regulated differently depending on end use: food ingredient, food supplement ingredient, flavouring, or potentially medicinal/herbal use. For Germany and Italy, I confirmed from BfR guidance that food supplements placed on the German market require importer/manufacturer notification to BVL with label submission, and EU food-law compliance applies; in addition, EU labelling rules and liquorice/glycyrrhizin-specific warnings may become relevant depending on formulation and concentration. For India, I confirmed that imported foods go through FSSAI clearance with document review, inspection, and possible sampling/testing. For China and Iceland, and for the exact product classification of licorice extract powder/block in each market, I could not fully verify the product-specific pathway within the research budget. I also could not verify product-specific tariff lines or whether any target use would trigger pharmaceutical rather than food rules. Iran-origin trade execution adds practical friction around payments, compliance screening, and counterparties even if the product itself is not prohibited.

시장 특성

구매자 우위 시장

특이사항

This is a bulk industrial ingredient market where buyers usually have multiple origin options and tend to scrutinize documentation, residue/composition specs, and consistency before switching suppliers. The seller also faces corridor-specific friction from Iran-origin trade compliance, which can narrow usable payment and logistics routes even when legal market access exists. End-use classification is especially important here: the same licorice extract can fall into different compliance expectations across food, supplement, flavour, or medicinal channels.

Pool → Targeted(20%) → Responded → Lead funnel. Responded·Lead는 본질 난이도 가중(low ×1.2 · moderate ×1.0 · high ×0.7). 최종 적합도는 Lead 범위 기준. Pool은 현재 매칭 기준 최소치이며 추가 발굴이 가능합니다(+).

Tridge discovery coverage is substantial in raw pool terms (total pool 63,927; targeted 10,665.4), but the real delivery lens is the expected Lead band after difficulty-weighted funnel attrition: total Lead expectation is 3.2~18.9 in the conservative scenario and 18.9~66.2 in the aggressive scenario. This supports a moderate verdict rather than high, because upside is large but a meaningful share of the pool sits in high-difficulty universes where conversion is suppressed, and the realistic floor is still limited relative to the headline pool. There is also a clear gap between intrinsic market fit and buyer reach: even with broad discoverability, axis ① is low due to regulatory ambiguity, end-use classification risk, and Iran-origin execution friction, so a large pool does not translate into straightforward deal yield.

AI 리서치 기반 회사 수출 역량 진단 — 관측 무역 데이터는 참고 지표 (특정 제품/시장 적합성은 아래 별도 표시)

무역 데이터 미매칭 — 진술 정보 기반 평가

Web research finds a small UK-registered commercial footprint for Health Options Europe rather than clear evidence of a systematized direct-export organization. LinkedIn describes the company as founded in 2012, privately held, with 2–10 employees in London, while Pharmaoffer lists it as a supplier/exporter of Iran-origin pharmaceutical products; however, I did not find public evidence of dedicated export teams, overseas branches, trade-fair history, or documented multi-market direct sales execution. The reference trade data is a no-match, so this diagnosis is made under the assumption that there is no observed export data in Tridge; this does not mean the company has never exported, as exports outside observed coverage may exist and reality may differ. Applying the skeptical standard that direct export capability requires concrete signs of repeatable channel-building and export operations, the available evidence supports a low rating despite the stated past export experience.

캠페인 가격 · 커밋 Lead

결정론적 산정 — AI가 아닌 시스템 룰

확약 = min(4축 점수 밴드, pool 이행 상한). 4축 = 제품·시장 적합도(high 3 · moderate 2 · low 0) + 수출 난이도(low 3 · moderate 2 · high 0) + 판매자 경쟁력(high 2 · moderate 1 · low 0 · 미제공 1) + Tridge 데이터 준비도(±1). 밴드 8+→5 · 6~7→4 · 4~5→3 · 2~3→2 · 그 외 1. 상한은 보수·공격 시나리오 Lead 상한의 중간값(중복 제거 union pool 기준). 커밋 0개는 판매 비권고에서만.

Tridge 데이터 준비도: 발굴 pool 중 수입 실적이 확인되는 비율 27.0% — 나머지는 이름·설명 매칭만으로 잡힌 미검증 회사다.

The committed lead count is fixed at 0, and this should be narrated as given. The input states that the 4-axis 확약 점수 was 3, which mapped to a target of 2건, while the pool-based delivery cap from 발굴 pool 53,327개 was 5건; the lower of the two governs the commitment. What held the number down was not the pool cap but the grading side: 제품·시장 적합도 low (+0) and 판매자 수출 경쟁력 low (+0) suppressed the target despite 수출 난이도 moderate (+2) and Tridge 데이터 준비도 27.0% (+1). Because this is a fixed deterministic verdict, it should be communicated verbatim rather than re-estimated from the broader funnel upside.